Aspen Pharmacare is planning to distribute Mounjaro (tirzepatide) into Sub-Saharan Africa, with launches anticipated in 2026 following SAHPRA’s approval of Mounjaro for chronic weight management.
In December 2024 Aspen, in partnership with Eli Lilly, introduced Mounjaro in SA for the treatment of type 2 diabetes. – Business Day (28 October 2025)